Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Burwell: ACA too ingrained to repeal

There are only about six months left in President Obama’s tenure at the White House, which means his administration is about to lose their jobs too. But some of them have a lot of work to do before they go. 

Thumbnail

CMS’s Slavitt says MACRA could be delayed

Testifying before the Senate Finance Committee, CMS Acting Administrator said it’s possible the agency will push back the Jan. 1, 2017, date for physicians to begin reporting under new standards set up by the Medicare Access and CHIP Reauthorization Act (MACRA).

Illinois co-op will shut down, leaving 49,000 looking for new coverage

Only seven of the original 23 health insurance co-ops set up by the Affordable Care Act will still be in operation, as Illinois’ Land of Lincoln Health (LLH) becomes the latest to close over risk adjustment payments.

21st Century Cures Act won’t get Senate vote before long recess

It’s been more than a year since the House passed the 21st Century Cures Act, which aims to speed up regulatory approval for medical devices and drugs, but the Senate’s chief advocate for the legislation said it’ll be at least another seven weeks before its put up for a vote.

AMA gives mixed reaction to CMS physician fee changes for 2017

The American Medical Association’s initial reaction to the proposed physician fee schedule for 2017 called the rule “a mix of meritorious and flawed proposals.”

Thumbnail

HHS issues new guidance on ransomware attacks

HHS’ Office of Civil Rights (OCR) has released its much-anticipated guidance on how healthcare organizations can better understand and respond to ransomware attacks, including defining such incidents as breaches that require affected individuals to be notified under HIPAA in most circumstances.

Anti-opioid abuse bill expected to pass this week despite fight over funding

The Senate will likely pass legislation to combat opioid addiction this week, even though Democrats hadn’t signed off on the bill over the lack of new federal funding for treatment and prevention programs.

What Purdue Pharma may have known about an OxyContin ring in L.A.

A Los Angeles Times investigation alleges Purdue Pharma, the maker of OxyContin, continued supplying clinics and pharmacies it suspected of trafficking the highly addictive drug and never alerted law enforcement.

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup